Table 2.
Paper section and topic | Description |
---|---|
Method | |
Experimental manipulations or interventions | Details of the interventions or experimental manipulations intended for each study condition, including control groups, and how and when manipulations or interventions were actually administered, specifically including: Content of the interventions or specific experimental manipulations Summary or paraphrasing of instructions, unless they are unusual or compose the experimental manipulation, in which case they may be presented verbatim Method of intervention or manipulation delivery Description of apparatus and materials used and their function in the experiment Specialized equipment by model and supplier Deliverer: who delivered the manipulations or interventions Level of professional training Level of training in specific interventions or manipulations Number of deliverers and, in the case of interventions, the M, SD, and range of number of individuals/units treated by each Setting: where the manipulations or interventions occurred Exposure quantity and duration: how many sessions, episodes, or events were intended to be delivered, how long they were intended to last Time span: how long it took to deliver the intervention or manipulation to each unit Activities to increase compliance or adherence (e.g., incentives) Use of language other than English and the translation method |
Units of delivery and analysis | Unit of delivery: How participants were grouped during delivery Description of the smallest unit that was analyzed (and in the case of experiments, that was randomly assigned to conditions) to assess manipulation or intervention effects (e.g., individuals, work groups, classes) If the unit of analysis differed from the unit of delivery, description of the analytical method used to account for this (e.g., adjusting the standard error estimates by the design effect or using multilevel analysis) |
Results | |
Participant flow | Total number of groups (if intervention was administered at the group level) and the number of participants assigned to each group: Number of participants who did not complete the experiment or crossed over to other conditions, explain why Number of participants used in primary analyses Flow of participants through each stage of the study (see Figure 1) |
Treatment fidelity | Evidence on whether the treatment was delivered as intended |
Baseline data | Baseline demographic and clinical characteristics of each group |
Statistics and data analysis | Whether the analysis was by intent-to-treat, complier average causal effect, other or multiple ways |
Adverse events and side effects | All important adverse events or side effects in each intervention group |
Discussion | Discussion of results taking into account the mechanism by which the manipulation or intervention was intended to work (causal pathways) or alternative mechanisms If an intervention is involved, discussion of the success of and barriers to implementing the intervention, fidelity of implementation Generalizability (external validity) of the findings, taking into account: The characteristics of the intervention How, what outcomes were measured Length of follow-up Incentives Compliance rates The “clinical or practical significance” of outcomes and the basis for these interpretations |